Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christiane Thienelt

Concepts (64)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
2
2009
1565
0.140
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
1049
0.140
Why?
Lung Neoplasms
1
2005
2339
0.100
Why?
Agranulocytosis
1
2010
30
0.090
Why?
Levamisole
1
2010
19
0.090
Why?
Heparin
1
2011
253
0.080
Why?
BRCA2 Protein
1
2009
53
0.080
Why?
Pregnancy Complications, Neoplastic
1
2009
53
0.080
Why?
Thrombophilia
1
2009
81
0.080
Why?
Cocaine
1
2010
148
0.070
Why?
Venous Thromboembolism
1
2011
283
0.070
Why?
Anticoagulants
1
2011
635
0.060
Why?
Carboplatin
1
2005
140
0.060
Why?
Cetuximab
1
2005
94
0.060
Why?
Exanthema
1
2005
74
0.060
Why?
Area Under Curve
1
2005
304
0.060
Why?
Paclitaxel
1
2005
217
0.060
Why?
Fatigue
1
2005
317
0.050
Why?
Survival Analysis
1
2005
1271
0.050
Why?
ErbB Receptors
1
2005
606
0.050
Why?
Neoplasm Staging
1
2005
1292
0.050
Why?
Immunohistochemistry
1
2005
1696
0.050
Why?
Dose-Response Relationship, Drug
1
2005
2003
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2005
758
0.040
Why?
Antibodies, Monoclonal
1
2005
1364
0.040
Why?
Breast Neoplasms
1
2009
2142
0.030
Why?
Follow-Up Studies
1
2005
4886
0.030
Why?
Time Factors
1
2005
6549
0.030
Why?
Intermittent Pneumatic Compression Devices
1
2011
4
0.020
Why?
Treatment Outcome
1
2005
10189
0.020
Why?
Organizational Case Studies
1
2011
74
0.020
Why?
Personnel, Hospital
1
2011
26
0.020
Why?
Reimbursement, Incentive
1
2011
36
0.020
Why?
Staff Development
1
2011
57
0.020
Why?
Crack Cocaine
1
2010
7
0.020
Why?
Leukopenia
1
2010
28
0.020
Why?
Adult
3
2010
35471
0.020
Why?
Drug Contamination
1
2010
51
0.020
Why?
Organizational Innovation
1
2011
138
0.020
Why?
Neutropenia
1
2010
134
0.020
Why?
Leukocyte Count
1
2010
325
0.020
Why?
Pregnancy Trimester, Second
1
2009
77
0.020
Why?
Mastectomy, Segmental
1
2009
85
0.020
Why?
Cyclophosphamide
1
2009
229
0.020
Why?
Pregnancy Trimester, First
1
2009
138
0.020
Why?
Bone Marrow
1
2010
270
0.020
Why?
Apoptosis Regulatory Proteins
1
2009
182
0.020
Why?
Lymph Node Excision
1
2009
164
0.020
Why?
Cost-Benefit Analysis
1
2011
567
0.020
Why?
Doxorubicin
1
2009
325
0.020
Why?
Aged
1
2005
22030
0.020
Why?
Male
3
2010
63498
0.020
Why?
Middle Aged
1
2005
31075
0.010
Why?
Humans
4
2011
129219
0.010
Why?
Practice Guidelines as Topic
1
2011
1493
0.010
Why?
Quality Improvement
1
2011
1100
0.010
Why?
Female
2
2009
68607
0.010
Why?
Risk Assessment
1
2011
3234
0.010
Why?
Prognosis
1
2009
3791
0.010
Why?
Colorado
1
2011
4412
0.010
Why?
Postoperative Complications
1
2011
2476
0.010
Why?
Infant, Newborn
1
2009
5753
0.010
Why?
Pregnancy
1
2009
6384
0.010
Why?
United States
1
2011
13873
0.010
Why?
Thienelt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)